Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
NCT Number: NCT06818591
In this study, the investigators observed the long-term incidence rate of osteoporosis in patients who received Helicobacter pylori eradication and examined differences by age and sex.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Seongnam-si, Gyeonggi-do, 13620, South Korea
In this study, the investigators observed the long-term incidence rate of osteoporosis in patients who received Helicobacter pylori eradication and examined differences by age and sex. In addition, the investigators will analyze the correlation between the incidence of osteoporosis by comparing confounding factors such as body mass index, steroid use, and proton pump inhibitor use as well as the eradication status of H. pylori.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
ㆍPatients tested Helicobacter pylori status
Exclusion criteria
ㆍPatients aged < 20 years ㆍPatients with unknown Helicobacter pylori bone density status ㆍPatients with with a history of gastric cancer ㆍPatients with prior Helicobacter pylori eradication therapy ㆍPatients with a history of osteoporosis
Followed for up to 20 years
Time frame: The patients were prospectively monitored until they either developed osteoporosis or reached the study endpoint in February 2023, whichever occurred first.
Seoul National University Bundang Hospital
Other
Preventive Effect of Helicobacter Pylori Eradication on Osteoporosis in Females: Prospective Observational Cohort Study for Up to 20 Years
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07651202
Glucose Metabolism Disorders, HELICOBACTER PYLORI INFECTIONS
Nanjing, Jiangsu, China
View Trial DetailsNCT07455448
HELICOBACTER PYLORI INFECTIONS
Nanjing, Jiangsu, China
View Trial DetailsNCT07374822
HELICOBACTER PYLORI INFECTIONS
Shenzhen, Guangdong, China
View Trial DetailsNCT07333001
HELICOBACTER PYLORI INFECTIONS
Jinan, Shandong, China
View Trial Details